SPMO vs. XBI

Last updated Jun 16, 2026

SPMO (Invesco S&P 500 Momentum ETF) and XBI (SPDR S&P Biotech ETF) are both exchange-traded funds - SPMO is a Momentum fund tracking the S&P 500 Momentum Index, while XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Both are passively managed. Over the past 10 years, SPMO returned 21.24%/yr vs 9.98%/yr for XBI. At a 0.45 correlation, their price movements are largely independent. SPMO charges 0.13%/yr vs 0.35%/yr for XBI.

Performance

SPMO vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P 500 Momentum ETF (SPMO) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SPMO achieves a 32.66% return, which is significantly higher than XBI's 11.87% return. Over the past 10 years, SPMO has outperformed XBI with an annualized return of 21.24%, while XBI has yielded a comparatively lower 9.98% annualized return.

SPMO

• 1D: 3.52%
• 1M: 10.01%
• YTD: 32.66%
• 6M: 33.70%
• 1Y: 50.00%
• 3Y*: 43.16%
• 5Y*: 24.34%
• 10Y*: 21.24%

XBI

• 1D: 1.95%
• 1M: 4.37%
• YTD: 11.87%
• 6M: 11.41%
• 1Y: 63.76%
• 3Y*: 16.08%
• 5Y*: 0.52%
• 10Y*: 9.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SPMO vs. XBI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SPMO Invesco S&P 500 Momentum ETF	32.66%	26.58%	45.82%	17.56%	-10.45%	22.64%	28.25%	25.93%	-0.92%	27.76%
XBI SPDR S&P Biotech ETF	11.87%	35.89%	1.01%	7.60%	-25.87%	-20.45%	48.33%	32.56%	-15.28%	43.77%

Correlation

The correlation between SPMO and XBI is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.40
Correlation (3Y) Calculated over the trailing 3-year period	0.44
Correlation (5Y) Calculated over the trailing 5-year period	0.47
Correlation (10Y) Calculated over the trailing 10-year period	0.48
Correlation (All Time) Calculated using the full available price history since Oct 12, 2015	0.45

SPMO vs. XBI - Sectors Allocation Comparison

Sectors	SPMO	XBI
Technology	54.9%	-
Industrials	11.1%	-
Communication Services	8.2%	-
Healthcare	6.4%	99.7%
Financial Services	5.9%	0.3%
Consumer Defensive	4.1%	-
Energy	3.1%	-
Utilities	2.5%	-
Basic Materials	1.5%	0.2%
Consumer Cyclical	1.2%	-
Real Estate	1.0%	-

Return for Risk

SPMO vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SPMO

SPMO Risk / Return Rank: 85
SPMO Sharpe Ratio Rank: 87
SPMO Sortino Ratio Rank: 84
SPMO Omega Ratio Rank: 86
SPMO Calmar Ratio Rank: 83
SPMO Martin Ratio Rank: 83

XBI

XBI Risk / Return Rank: 86
XBI Sharpe Ratio Rank: 85
XBI Sortino Ratio Rank: 83
XBI Omega Ratio Rank: 74
XBI Calmar Ratio Rank: 94
XBI Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SPMO vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500 Momentum ETF (SPMO) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SPMO	XBI	Difference
Sharpe ratio: Return per unit of total volatility	2.55	2.45	+0.09
Sortino ratio: Return per unit of downside risk	3.34	3.29	+0.05
Omega ratio: Gain probability vs. loss probability	1.46	1.39	+0.07
Calmar ratio: Return relative to maximum drawdown	3.96	6.59	-2.64
Martin ratio: Return relative to average drawdown	14.96	19.47	-4.51

SPMO vs. XBI - Sharpe Ratio Comparison

The current SPMO Sharpe Ratio is 2.55, which is comparable to the XBI Sharpe Ratio of 2.45. The chart below compares the historical Sharpe Ratios of SPMO and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

SPMO vs. XBI - Drawdown Comparison

The maximum SPMO drawdown since its inception was -30.95%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SPMO and XBI.

Drawdown Indicators

	SPMO	XBI	Difference
Max Drawdown Largest peak-to-trough decline	-30.95%	-63.89%	+32.94%
Max Drawdown (1Y) Largest decline over 1 year	-12.70%	-9.72%	-2.98%
Max Drawdown (3Y) Largest decline over 3 years	-20.13%	-32.99%	+12.86%
Max Drawdown (5Y) Largest decline over 5 years	-22.74%	-54.71%	+31.97%
Max Drawdown (10Y) Largest decline over 10 years	-30.95%	-63.89%	+32.94%
Current Drawdown Current decline from peak	0.00%	-21.16%	+21.16%
Average Drawdown Average peak-to-trough decline	-4.60%	-20.93%	+16.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.35%	3.29%	+0.06%

Volatility

SPMO vs. XBI - Volatility Comparison

Invesco S&P 500 Momentum ETF (SPMO) and SPDR S&P Biotech ETF (XBI) have volatilities of 10.78% and 10.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SPMO	XBI	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.78%	10.55%	+0.23%
Volatility (6M) Calculated over the trailing 6-month period	17.04%	20.83%	-3.79%
Volatility (1Y) Calculated over the trailing 1-year period	19.78%	26.18%	-6.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.71%	32.22%	-12.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	20.52%	32.03%	-11.51%

SPMO vs. XBI - Expense Ratio Comparison

SPMO has a 0.13% expense ratio, which is lower than XBI's 0.35% expense ratio.

Dividends

SPMO vs. XBI - Dividend Comparison

SPMO's dividend yield for the trailing twelve months is around 0.64%, more than XBI's 0.32% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SPMO Invesco S&P 500 Momentum ETF	0.64%	0.73%	0.48%	1.63%	1.66%	0.52%	1.27%	1.39%	1.05%	0.77%	1.94%	0.36%
XBI SPDR S&P Biotech ETF	0.32%	0.37%	0.15%	0.02%	0.00%	0.04%	0.20%	0.00%	0.28%	0.24%	0.26%	0.61%

Frequently Asked Questions

Can I hold both SPMO and XBI in my portfolio?

SPMO and XBI have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SPMO or XBI?

SPMO has higher volatility (10.78%) compared to XBI (10.55%). In terms of maximum drawdown, SPMO dropped -30.95% vs XBI's -63.89%.

Which ETF is better, SPMO or XBI?

On 10-year performance, SPMO leads with 21.24% vs 9.98% for XBI. On fees, SPMO is cheaper at 0.13% per year. On volatility, XBI has been the lower-risk option at 10.55%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, SPMO or XBI?

Over the 10-year period, SPMO has performed better with a 21.24% return vs 9.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, SPMO or XBI?

SPMO is cheaper with a 0.13% expense ratio, compared with 0.35% for XBI.

Which ETF pays a higher dividend yield, SPMO or XBI?

SPMO has the higher dividend yield at 0.64%, compared with 0.32% for XBI.

What is the main difference between SPMO and XBI?

SPMO is categorized as Momentum, while XBI is Health & Biotech Equities. SPMO tracks S&P 500 Momentum Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: Invesco and State Street. Their fees differ too: 0.13% for SPMO and 0.35% for XBI.

Which has better risk-adjusted returns?

SPMO currently has the higher Sharpe Ratio (2.55 vs 2.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.